The abstract is read at the publisher; the summary is JClub's.
RA susceptibility gene expression in early treatment-naïve synovial tissue is pathotype-specific, separating lympho-myeloid from diffuse-myeloid and pauci-immune fibroid, with strongest immune bias in lympho-myeloid.
- Why it matters: GWAS risk loci do not explain how genetic predisposition maps onto divergent early synovial immunopathology. Pathotype-specific expression could clarify which disease mechanisms genetic signals reflect.
- What they did: Using synovial RNA sequencing from early RA cohorts (PEAC N = 87; Flinders N = 18), the study compared differential expression across lympho-myeloid, diffuse-myeloid, and pauci-immune fibroid, then performed pathway enrichment with GWAS-identified susceptibility genes.
- The result: RA susceptibility genes were enriched among lympho-myeloid upregulated genes and linked to lymphocyte activation and differentiation, correlating with disease activity; OA susceptibility genes were upregulated in diffuse-myeloid and fibroid, most pronounced in ACPA-positive and directionally consistent in ACPA-negative.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.